Table 3.
The content of determined parameters in the serum during TAA induction (x ± s).
| Group | (A/T) | ( AST) | (Hyp) | (IVC) | ( LN ) | (PC-III) |
|---|---|---|---|---|---|---|
| (%) | (IU/L) | (ng/mL) | (ng/mL) | (ng/mL) | (ng/mL) | |
| Normal | 46.53 ± 12.13 | 36.80 ± 6.94 | 137.14 ± 12.98 | 18.14 ± 3.08 | 10.28 ± 7.49 | 7.44 ± 4.38 |
| Model | 40.45 ± 11.40 | 54.09 ± 13.26 | 193.96 ± 14.29** | 21.60 ± 4.07** | 17.78 ± 6.68** | 10.88 ± 3.25** |
| Group | (Col I) | (HA) | (T.Bil) | (A/G) | (Alb) | (TP) |
| (ng/mL) | (ng/mL) | (ng/mL) | (%) | (mg/mL) | (mg/mL) | |
| Normal | 31.48 ± 5.27 | 5.26 ± 5.49 | 5.55 ± 1.19 | 83.99 ± 14.45 | 37.27 ± 11.56 | 79.62 ± 8.64 |
| Model | 48.10 ± 14.68** | 16.86 ± 8.6** | 4.91 ± 1.75 | 73.52 ± 11.92 | 32.09 ± 9.62 | 79.28 ± 7.69 |
**P < .05, compared to the normal group.